Why Is Hims & Hers Stock Soaring After FDA’s Announcment?

All NewsApril 16, 2026

Hims & Hers stock rises as FDA plans to ease peptide therapy rules, opening new revenue opportunities and shifting regulatory outlook.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Why Is Hims & Hers Stock Soaring After FDA’s Announcment?

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

What are the main events for today?

China’s economy picks up pace at 4.5% growth

Zoom adds ‘proof of human’ badges to show you’re not a deepfake

Amazon has a bestselling metal storage shed with lockable doors for only $110

Rising interest rates derail property recovery as buyers recut deals